{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2Fnovel-drug-development-part-2-alzheimers-disease-june-2020-bEnLgBRD","width":444,"version":"1.0","type":"rich","title":"Novel Drug Development-Part 2: Alzheimer's Disease June 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/ea1423c0-ca18-40a2-adfc-82e34325e77d/slide1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/490c9b4d-40b9-47b1-8781-b621bc5451e5\" height=\"200\" width=\"100%\" title=\"Novel Drug Development-Part 2: Alzheimer&apos;s Disease June 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help! \n\nEllen tells you about more papers on drugs in development from June 2020.   These studies encompass those done in vitro or using computational models, but not animal testing. This time around, she will be focusing on papers where the target is tau protein, the cholinergic system, metabolism, mitochondria, neuroinflammation, and autophagy from June 2020! If you're interested in hearing more about treatments for AD, you should also check out our episodes on pre-clinical and clinical testing. "}